
CDMOs in Radiopharma: Why Legacy Systems Threaten Scale-Up
Guest Editorial by Molly McGaughan, Co-founder and Managing Director, Firm Contract development and manufacturing organizations sit much closer to the patient experience than most people realize. Their decisions shape whether a dose arrives on time, whether rescheduling is possible, and

